Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy

Vascular endothelial growth factor receptors (VEGFRs) are a family of receptor protein tyrosine kinases that play an important role in the regulation of tumor-induced angiogenesis. Currently, VEGFR inhibitors have been widely used in the treatment of various tumors. However, current VEGFR inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yun, Li, Yang, Wang, Yuxi, Lin, Congcong, Zhang, Dan, Chen, Juncheng, Ouyang, Liang, Wu, Fengbo, Zhang, Jifa, Chen, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263050/
https://www.ncbi.nlm.nih.gov/pubmed/35799213
http://dx.doi.org/10.1186/s13045-022-01310-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263050/
https://www.ncbi.nlm.nih.gov/pubmed/35799213
http://dx.doi.org/10.1186/s13045-022-01310-7

Ejemplares similares